Effect of repetitive levosimendan treatment on clinical outcomes of chronic heart failure patients: focus on optimal patient selection based on novel cardiac biomarkers.
Phase of Trial: Phase IV
Latest Information Update: 20 Feb 2017
At a glance
- Drugs Levosimendan (Primary)
- Indications Heart failure; Myocardial ischaemia
- Focus Therapeutic Use
- 20 Feb 2017 New trial record